Cargando…
Vitamin E acetate as linactant in the pathophysiology of EVALI
The recent identification of Vitamin E acetate as one of the causal agents for the e-cigarette, or vaping, product use associated lung injury (EVALI) is a major milestone. In membrane biophysics, Vitamin E is a linactant and a potent modulator of lateral phase separation that effectively reduces the...
Autor principal: | Lee, Hanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422838/ https://www.ncbi.nlm.nih.gov/pubmed/33254504 http://dx.doi.org/10.1016/j.mehy.2020.110182 |
Ejemplares similares
-
Modulation
of a Small Two-Domain Lipid Vesicle by
Linactants
por: Li, Zhenlong, et al.
Publicado: (2014) -
Does ‘Dry Hit’ vaping of vitamin E acetate contribute to EVALI? Simulating toxic ketene formation during e-cigarette use
por: Narimani, Milad, et al.
Publicado: (2020) -
Pulmonary Toxicity and Inflammatory Response of Vape Cartridges Containing Medium-Chain Triglycerides Oil and Vitamin E Acetate: Implications in the Pathogenesis of EVALI
por: Muthumalage, Thivanka, et al.
Publicado: (2020) -
EVALI IN THE ERA OF COVID-19
por: PUTHUMANA, ROSE, et al.
Publicado: (2021) -
Elemental Analysis of Tetrahydrocannabinol and Nicotine
E-Liquids Related to EVALI
por: Kubachka, Kevin M., et al.
Publicado: (2021)